Patent · US Active

GDF15 in glaucoma and methods of use thereof

US11137408B2 · kind B2 · utility

1Cited by

2References

8Claims

0Family size

Assignee

Washington University · US

Inventors

Rajendra S. Apte · Chesterfield, US
Jun Yoshino · Fuji, JP

Key dates

Filing date	Jan 30, 2017
Grant date	Oct 5, 2021
Priority date	—
Expiry date	Sep 1, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present disclosure provided methods for determining the severity of glaucoma using the expression levels of GDF15. Determining the severity of glaucoma aids in treatment decisions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.